The UA has surpassed it's performance expectations for annual measures in technology commercialization, and five of the 16 new startups formed in the last year were generated from research conducted by BIO5 Institute members. Reglagene, Regulonix, Aqualung Therapeutics, Iluminos Therapeutics, and MCR Therapeutics are companies using cutting edge research to solve health problems and cure disease.
Related
